Mahkam Zanganeh
Co-CEO & President at Summit Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Summit Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Summit Therapeutics Inc. June 12, 2025100.0%
-
Summit Therapeutics Inc. June 12, 2024100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Summit Therapeutics Inc. | Open-market purchase | +3,810,000 | $13.12 | $49,987,200 |
| Jun 4, 2026 | Summit Therapeutics Inc. | Open-market purchase | +100,000 | $14.60 | $1,460,000 |
| Oct 21, 2025 | Summit Therapeutics Inc. | Grant or award | +266,808 | $18.74 | $4,999,982 |
| Oct 21, 2025 | Summit Therapeutics Inc. | Open-market purchase | +26,680 | $18.74 | $499,983 |
| Oct 21, 2025 | Summit Therapeutics Inc. | Grant or award | +13,980,789 | $18.74 | $261,999,986 |
| Sep 11, 2025 | Summit Therapeutics Inc. | Open-market purchase | +5,000 | $18.07 | $90,350 |
| Sep 10, 2025 | Summit Therapeutics Inc. | Open-market purchase | +333,394 | $17.68 | $5,894,406 |
| May 30, 2025 | Summit Therapeutics Inc. | Option exercise | +74,545 | $2.64 | $196,799 |
| Apr 8, 2025 | Summit Therapeutics Inc. | In-the-money exercise | +3,985,055 | $1.58 | $6,296,387 |
| Feb 3, 2025 | Pulse Biosciences Inc | In-the-money exercise | +30,121 | $11.00 | $331,331 |
| Jan 24, 2025 | Pulse Biosciences Inc | In-the-money exercise | +30,121 | $11.00 | $331,331 |
| Oct 3, 2024 | Summit Therapeutics Inc. | In-the-money exercise | +315,681 | $1.58 | $498,776 |
| Sep 11, 2024 | Summit Therapeutics Inc. | Grant or award | +44,052 | $22.70 | $999,980 |
| Jul 3, 2024 | Pulse Biosciences Inc | In-the-money exercise | +60,242 | — | — |
| Mar 27, 2024 | Summit Therapeutics Inc. | Open-market purchase | +26,000 | $3.72 | $96,720 |
Questions about Mahkam Zanganeh
What boards is Mahkam Zanganeh on?
Mahkam Zanganeh sits on the boards of Pulse Biosciences Inc and Summit Therapeutics Inc.
What company is Mahkam Zanganeh the CEO of?
Mahkam Zanganeh is Co-CEO & President of Summit Therapeutics Inc.
How long has Mahkam Zanganeh served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.